Massachusetts Institute of Technology (MIT)’s Koch Institute to use Roche LightCycler(R) 480 System to Help Advance Cancer Research

PENZBERG, Germany--(BUSINESS WIRE)--Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the David H. Koch Institute for Integrative Cancer Research at MIT will be using the Roche LightCycler® 480 System, a real-time polymerase chain reaction (PCR) system for the analysis of gene expression and genetic variation, in advanced cancer research.